In addition, there is also evidence that cachexia as defined at the International Cachexia Conference in 2011 [15] is associated with increased chemotherapy toxicity [16,17], and there is preliminary evidence that cachexia is associated with worse outcomes in patients treated with anti-PD1/anti-PDL1 monoclonal antibodies [18,19]. Here, CD274 is linked to Cachexia.